The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Nvidia and Eli Lilly and Co. are partnering to create an artificial intelligence lab in the San Francisco Bay Area to ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...

Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan ...

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

A giant robot at CU Anschutz Medical Campus is busy doing lifesaving work. Dan LaBarbera is the founding director at the Center for Drug Discovery at the campus. “The robot can work 24 hours a day, ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery companies ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round.